<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Jacobson, Anne</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Chalmers, John</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Intensive Glucose Control and Blood Pressure Reduction Additive in Type 2 Diabetes Mellitus</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2008-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">11-12</style></pages><abstract><style  face="normal" font="default" size="100%">Interventions that are designed to lower blood pressure or increase glucose control both improve outcomes in patients with type 2 diabetes mellitus. Together, these strategies provide even greater protection against diabetes-related complications, according to new findings from the Action in Diabetes and Vascular Disease [ADVANCE] trial.</style></abstract><number><style face="normal" font="default" size="100%">7</style></number><volume><style face="normal" font="default" size="100%">8</style></volume></record></records></xml>